HUNT DOUGLAS M
See Remarks
HUNT DOUGLAS M has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jul 9, 2026.
On the most recent filing, HUNT DOUGLAS M is listed as See Remarks at PUMA BIOTECHNOLOGY, INC. Inside the rolling window, HUNT DOUGLAS M reported no open-market purchases and 3 open-market sales totaling $123K in PBYI. The largest disclosed transaction in the window is a sale of 8,460 PBYI shares on Jul 6, 2026, worth $70K.
Companies traded
Other insiders at PBYI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$123K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has HUNT DOUGLAS M made?
HUNT DOUGLAS M has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does HUNT DOUGLAS M trade?
HUNT DOUGLAS M has filed SEC Form 4 disclosures for 1 company, including PBYI.
When was HUNT DOUGLAS M's most recent SEC Form 4 filing?
HUNT DOUGLAS M's most recent SEC Form 4 filing on Tracefour is dated Jul 9, 2026.
What is HUNT DOUGLAS M's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, HUNT DOUGLAS M is listed as See Remarks.
What is HUNT DOUGLAS M's total buy and sell value in the current window?
Inside the rolling retention window, HUNT DOUGLAS M bought $0 and sold $123K based on SEC Form 4 filings.
What was HUNT DOUGLAS M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 8,460 PBYI shares on 2026-07-06, worth $70K, per SEC Form 4 filings.